AbbVie Inc.
SYNTHETIC ROUTE TO ANTI-VIRAL AGENTS
Last updated:
Abstract:
The invention provides methods of synthesizing a viral protease inhibitor in high yield, without using expensive catalysts or challenging reaction conditions.
Status:
Application
Type:
Utility
Filling date:
27 Sep 2019
Issue date:
26 Mar 2020